Stock Report

All about this stock under one free report Last Updated: 04-Nov-2026

Stock Rating

Is this stock worth it? Our ratings reveal the truth.

Wealth Insight New Issue

Serious stock insights. No fluff. No FOMO.

Recently Viewed

Cravatex Key Ratios

Stock Card factsheet watchlist-stock-modal share-fund-plan-icon

BSE: 509472

₹335.00

up-down-arrow ₹23.50 (7.54%)

As on 04-Nov-2026IST

Market cap

info icon

₹87 Cr

Revenue (TTM)

info icon

₹162 Cr

P/E Ratio

info icon

10.9

P/B Ratio

info icon

0.7

Div. Yield

info icon

3.8 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue 65.91 3.92 -3.30 -17.15 -23.02
EBIT 173.38 12.90 24.17 22.05 12.60
Net Profit 952.62 -11.39 44.52 36.61 18.24
EPS 955.28 -11.39 44.51 -55.80 18.24
Book Value -- -- 12.22 8.95 44.15
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsTTMMar-26Mar-25
EBIT-Margin info -105.96-4.84-2.94-5.23-1.82
Net Margin info 35.273.414.514.052.63
Return on equity info 23.9358.496.636.024.71
Return on Capital info 26.8117.32--7.926.62
Return on Assets info 19.466.065.284.743.64
Debt to Equity (x) info ----0.000.000.00

Profitability

View Detailed Peer Comparison

ROCE

--

--

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Cravatex
--
7.92
6.62
6.87
68.80
Peer Median
--
17.60
13.65
20.51
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROE

6.63

Lower than Peers by 5.13

Profit after tax / Average Net worth * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Cravatex
6.63
6.02
4.71
5.05
276.70
Peer Median
11.76
12.93
11.89
15.90
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROA

5.28

Lower than Peers by 1.50

Profit after tax / Average Total assets * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Cravatex
5.28
4.74
3.64
3.70
23.51
Peer Median
6.78
6.27
5.53
7.64
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Margin

-2.94

Lower than Peers by 10.78

Operating profit (EBIT) / Net Sales * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Cravatex
-2.94
-5.23
-1.82
-4.70
-9.14
Peer Median
7.85
9.07
8.19
8.54
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Margin

4.51

Lower than Peers by 2.61

Net profit / Total Income (Net sales plus other income) * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Cravatex
4.51
4.05
2.63
2.21
11.42
Peer Median
7.11
6.06
5.47
6.56
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Profit Margin

--

--

(Net profit + Depreciation) / Gross Sales * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Cravatex
--
5.50
3.63
3.31
14.91
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Growth

View Detailed Peer Comparison

Revenue Growth

-3.30

Lower than Peers by 13.32

Year on year growth in net sales

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Cravatex
-3.30
-13.17
-14.25
-59.77
-15.26
Peer Median
10.02
14.55
29.72
7.05
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Growth

24.17

Higher than Peers by 11.23

Year on year growth in operating profit (EBIT)

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Cravatex
24.17
-149.88
66.84
79.29
-134.21
Peer Median
12.94
29.38
23.89
18.97
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Profit Growth

44.52

Higher than Peers by 28.16

Year on year growth in profit after tax

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Cravatex
44.52
40.77
0.02
-91.81
396.33
Peer Median
16.36
24.69
23.03
10.54
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EPS Growth

44.51

Higher than Peers by 38.35

Year on year growth in earnings per share

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Cravatex
44.51
40.77
0.02
-91.81
396.34
Peer Median
6.16
12.38
4.03
9.38
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Book Value Growth

--

--

Year on year growth in book value per share

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Cravatex
--
12.22
7.80
6.89
285.59
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Solvency

View Detailed Peer Comparison

Debt to Equity

--

--

Total debt / Net worth

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Cravatex
--
--
--
--
--
Peer Median
0.01
0.42
0.49
0.32
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Short term debt to equity ratio

--

--

(Short term borrowings / Net worth)

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Cravatex
--
--
--
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Current Ratio

4.36

Higher than Peers by 2.60

Current Assets / Current Liabilities and Provisions

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Cravatex
4.36
5.62
4.22
5.11
2.95
Peer Median
1.76
1.68
1.76
1.79
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Quick Ratio

3.67

Higher than Peers by 2.62

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Cravatex
3.67
4.68
3.86
4.64
2.27
Peer Median
1.04
1.40
0.99
1.05
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Interest Coverage

32.62

Higher than Peers by 28.75

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Cravatex
32.62
24.60
16.41
16.10
5.22
Peer Median
3.87
3.82
3.00
4.17
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

13.60

Lower than Peers by 16.34

Debtors outstanding / Net Sales * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Cravatex
13.60
10.82
13.79
6.83
5.20
Peer Median
29.94
35.47
32.90
23.57
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Asset Turnover

1.07

Higher than Peers by 0.14

Sales / Average Total Assets

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Cravatex
1.07
1.05
1.31
1.55
2.01
Peer Median
0.92
1.06
1.13
1.06
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Receivable days

--

--

Average Debtors / Sales * 365

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Cravatex
--
48.74
39.71
36.08
57.77
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Inventory Days

--

--

Average Inventory / Sales * 365

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Cravatex
--
41.71
23.26
35.77
44.71
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Payable days

--

--

Average Creditors / Cost of goods sold * 365

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Cravatex
--
49.54
38.15
40.41
30.99
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Conversion Cycle

--

--

Receivable Days + Inventory Days - Payable Days

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Cravatex
--
40.91
24.82
31.43
71.48
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Valuation

View Detailed Peer Comparison

Price / Earnings

10.91

Lower than Peers by 19.99

Current share price divided by earning per share in the last twelve months

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Cravatex
10.91
11.60
18.34
23.40
1.40
Peer Median
30.89
25.12
36.20
31.36
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Price / Book Value

0.72

Lower than Peers by 1.85

Current share price divided by book value per share in the latest financial year

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Cravatex
0.72
0.66
0.83
1.14
0.90
Peer Median
2.57
2.80
4.03
3.69
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Dividend Yield

3.85

--

Dividend per share in the past twelve months divided by current share price

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Cravatex
3.85
4.26
3.65
0.69
0.47
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EV/EBITDA

0.24

--

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Cravatex
0.24
0.22
1.58
4.37
-1.51
Peer Median
--
12.74
22.54
19.25
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Market Cap

87

Lower than Peers by 922

Current Share price multiplied by latest total number of shares outstanding

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Cravatex
87
79
89
113
83
Peer Median
1,010
479
714
610
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
loading...
loading...
loading...

Mutual Fund Insight turns 24! 🎉 Get 2 FREE anniversary guides: The Right SIP + The Big Funds